NANJING GAOKE COMPANY LIMITED Nanjing Gaoke Company Limited Stock
Equities
600064
CNE000000PX6
Real Estate Development & Operations
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.46 CNY | +1.57% |
|
+2.05% | +6.95% |
| Jan. 26 | Nanjing Gaoke's Q4 Contracted Sales Drop 69% | MT |
| 2023 | Nanjing Gaoke Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
| Sales 2021 | 4.93B 682M | Sales 2022 | 4.49B 620M | Capitalization | 11.44B 1.58B |
|---|---|---|---|---|---|
| Net income 2021 | 2.35B 325M | Net income 2022 | 2.4B 332M | EV / Sales 2021 | 2.6 x |
| Net Debt 2021 | 1.28B 176M | Net Debt 2022 | 3.99B 551M | EV / Sales 2022 | 3.44 x |
| P/E ratio 2021 |
4.91
x | P/E ratio 2022 |
4.76
x | Employees | 562 |
| Yield 2021 |
6.42% | Yield 2022 |
6.35% | Free-Float | 54.96% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.57% | ||
| 1 week | +2.05% | ||
| Current month | +3.36% | ||
| 1 month | +2.70% | ||
| 3 months | +6.95% | ||
| 6 months | +4.70% | ||
| Current year | +6.95% |
1 week
6.32
6.46
1 month
6.196.46
Current year
5.716.46
1 year
5.717.40
3 years
5.658.21
5 years
5.658.98
10 years
2.9513.04
| Managers | Title | Age | Since |
|---|---|---|---|
Ke Jin Zhou
DFI | Director of Finance/CFO | 49 | 16-12-21 |
Bao Min Xiao
CHM | Chairman | 62 | 16-12-21 |
Yang Jun Lu
PSD | President | 53 | 09-10-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yi Min Xu
CHM | Chairman | 61 | 03-05-31 |
Yang Jun Lu
PSD | President | 53 | 09-10-31 |
Qiao Gen Feng
BRD | Director/Board Member | 63 | 16-12-21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-15 | 6.46 | +1.57% | 20,199,420 |
| 24-04-12 | 6.36 | -0.16% | 9,881,277 |
| 24-04-11 | 6.37 | -0.16% | 9,743,047 |
| 24-04-10 | 6.38 | -0.47% | 12,894,000 |
| 24-04-09 | 6.41 | +1.26% | 13,272,460 |
End-of-day quote Shanghai S.E., April 14, 2024
More quotes
NANJING GAOKE COMPANY LIMITED is a China-based company, principally engaged in real estate and municipal businesses, medical health business and equity investment business. Its real estate business includes residential development, commercial operations and property management, among others. Its medical health business includes the research and development, manufacture and sales of pharmaceuticals. The Company operates its businesses primarily in Nanjing, Jiangsu province, China.
Calendar
2024-04-26
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +6.95% | 1.54B | |
| -13.70% | 21.67B | |
| +8.89% | 10.66B | |
| -31.74% | 10.6B | |
| -30.49% | 7.43B | |
| -1.85% | 7.35B | |
| +5.38% | 6.96B | |
| -7.99% | 5.93B | |
| +12.57% | 3.78B | |
| -6.13% | 3.54B |
- Stock Market
- Equities
- 600064 Stock
